Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qiwēi Guǐbǎo granules in early ovarian insufficiency (kidney yin deficiency) – randomized double-blind placebo-controlled phase II
CTR20210903Phase 2Active
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Mar 2022
- Countries
- 1
01
Overview
A Phase 2 trial of Qiwei Guibao granules in ovarian hypofunction (POI), sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Mar 2022; status: active.
02
Drugs
Qiwei Guibao granules
03
Conditions
ovarian hypofunction (POI)
Beyond the preview
Go deeper on CTR20210903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210903.